Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023 Read more about Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023
Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients Read more about Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results Read more about Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA Read more about Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA
Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK® (sodium thiosulfate injection) to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric Patients Read more about Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK® (sodium thiosulfate injection) to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric Patients
Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update
Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United States Read more about Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United States
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from Petrichor Read more about Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from Petrichor
Fennec Pharmaceuticals Announces FDA Approval of PEDMARK® (Sodium Thiosulfate Injection) Read more about Fennec Pharmaceuticals Announces FDA Approval of PEDMARK® (Sodium Thiosulfate Injection)
Fennec Pharmaceuticals Closes First $5 Million Investment From Petrichor Read more about Fennec Pharmaceuticals Closes First $5 Million Investment From Petrichor
